BREAKING NEWS: Cameron Says Labour-SNP Pact ‘Frightening’ as Scots Woo Miliband

Bloomberg - Home Search
Bristol-Myers Squibb Co (BMY:US)
update Apr 17
65.35 +1.67 (+2.62%)
High 66.26
Low 64.82
Open 66.08
Volume 14385979
Time Apr 17
intra-day chart
High 69.20
Low 46.30
P/E 47.31
Return +35.68%
Mkt Cap 108.917 B
one year chart
Company News
Company Profile
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.